IBDEI0AH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4521,1,5,0)
 ;;=5^Ca Renal Pelvis
 ;;^UTILITY(U,$J,358.3,4521,2)
 ;;=   ^267264
 ;;^UTILITY(U,$J,358.3,4522,0)
 ;;=171.9^^23^232^82
 ;;^UTILITY(U,$J,358.3,4522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4522,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,4522,1,5,0)
 ;;=5^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,4522,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,4523,0)
 ;;=186.9^^23^232^31
 ;;^UTILITY(U,$J,358.3,4523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4523,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,4523,1,5,0)
 ;;=5^Ca Testicular
 ;;^UTILITY(U,$J,358.3,4523,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,4524,0)
 ;;=198.5^^23^232^68
 ;;^UTILITY(U,$J,358.3,4524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4524,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,4524,1,5,0)
 ;;=5^Mets to Bone or Bone Marrow
 ;;^UTILITY(U,$J,358.3,4524,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,4525,0)
 ;;=198.3^^23^232^69
 ;;^UTILITY(U,$J,358.3,4525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4525,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,4525,1,5,0)
 ;;=5^Mets to Brain
 ;;^UTILITY(U,$J,358.3,4525,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,4526,0)
 ;;=197.7^^23^232^18
 ;;^UTILITY(U,$J,358.3,4526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4526,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,4526,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,4526,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,4527,0)
 ;;=197.0^^23^232^70
 ;;^UTILITY(U,$J,358.3,4527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4527,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,4527,1,5,0)
 ;;=5^Mets to Lung
 ;;^UTILITY(U,$J,358.3,4527,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,4528,0)
 ;;=196.2^^23^232^71
 ;;^UTILITY(U,$J,358.3,4528,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4528,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,4528,1,5,0)
 ;;=5^Mets to Lymph Nodes,Abdominal
 ;;^UTILITY(U,$J,358.3,4528,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,4529,0)
 ;;=196.3^^23^232^72
 ;;^UTILITY(U,$J,358.3,4529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4529,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,4529,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,4529,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,4530,0)
 ;;=196.0^^23^232^73
 ;;^UTILITY(U,$J,358.3,4530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4530,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,4530,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,4530,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,4531,0)
 ;;=196.1^^23^232^74
 ;;^UTILITY(U,$J,358.3,4531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4531,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,4531,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,4531,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,4532,0)
 ;;=196.8^^23^232^75
 ;;^UTILITY(U,$J,358.3,4532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4532,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,4532,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,4532,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,4533,0)
 ;;=V10.51^^23^232^33
 ;;^UTILITY(U,$J,358.3,4533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4533,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,4533,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,4533,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,4534,0)
 ;;=V10.3^^23^232^34
 ;;^UTILITY(U,$J,358.3,4534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4534,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,4534,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,4534,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,4535,0)
 ;;=V10.41^^23^232^35
 ;;
 ;;$END ROU IBDEI0AH
